Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 2

Status

Recruiting 2Unknown 1Completed 1

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Rectal Neoplasms 4Squamous Cell Carcinoma of Head and Neck 2Nasopharyngeal Carcinoma 2Lung Neoplasms 2Adenocarcinoma Of Esophagus 2Melanoma 1Laryngeal Neoplasms 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Esophageal Squamous Cell Carcinoma 1Colorectal Neoplasms 1Colonic Neoplasms 1Clinical Stage III Gastric Cancer AJCC v8 1Carcinoma, Non-Small-Cell Lung 1Barrett Esophagus 1Adenocarcinoma of Lung 1Adenocarcinoma 1

Interventions

Oxaliplatin 146Fluorouracil 137Capecitabine 121Leucovorin 106Irinotecan 85Radiotherapy 66Bevacizumab 64Cetuximab 46Folfox protocol 27Surgical Procedures, Operative 23Radiation 23Drug Therapy 22Panitumumab 19XELOX 18Chemotherapy, Adjuvant 15Neoadjuvant Therapy 14Radiotherapy, Intensity-Modulated 13Chemoradiotherapy 13Magnetic Resonance Spectroscopy 11regorafenib 10Nivolumab 10Floxuridine 10sintilimab 8raltitrexed 8Specimen Handling 8IFL protocol 8Celecoxib 8Biopsy 8trifluridine tipiracil drug combination 7tislelizumab 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Rectal Neoplasms × Endoscopy × Clear all
NCT04864067 2026-05-08

NOAHS-ARC

Servicio de Salud Metropolitano Sur Oriente

Phase 2 Completed
39 enrolled
Gastrointestinal

Adenocarcinoma, Rectal Neoplasms

NCT07405476 2026-04-17

Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment

Emory University

Phase 2 Recruiting
38 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT06780787 2025-06-26

FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery

City of Hope Medical Center

Phase 2 Recruiting
26 enrolled
Gastrointestinal

Rectal Neoplasms

NCT02280070 2014-10-31

RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301).

Clinical Research Support Center Kyush

Phase 2 Unknown
110 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡